Abnormal elevations in ammonia have been implicated in the pathogenesis of
Alzheimer's disease. However, the biochemical mechanism(s) leading to incre
ased ammonia in Alzheimer's disease have not yet been identified. A potenti
al source of increased ammonia production is adenosine monophosphate (AMP)
deaminase, an important enzyme in the regulation of the purine nucleotide c
ycle and adenylate energy charge. AMP deaminase activity is expressed in hu
man brain and converts AMP to inosine monophosphate with the release of amm
onia. We have investigated AMP deaminase activity in postmortem brain tissu
e from Alzheimer's dic;ease subjects and age-matched controls. Compared to
control brain, Alzheimer's disease brain AMP deaminase activity is 1.6- to
2.4-fold greater in the regions examined-the cerebellum, occipital cortex,
and temporal cortex. Similar increases in AMP deaminase protein and mRNA le
vels are observed in Alzheimer's disease brain. These results suggest that
increased AMP deaminase activity may augment ammonia levels in the brain in
Alzheimer's disease. (C) 1998 Elsevier Science Inc.